azacitidine has been researched along with Chromosomal Fragility in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dev, VG; Mixon, C | 1 |
Daniel, A; Ekblom, L; Phillips, S | 1 |
Adolph, S; Djalali, M; Hameister, H; Steinbach, P; Winking, H | 1 |
Sutherland, GR | 1 |
Berger, C; Coyle-Morris, J; Gemmill, RM; Glover, TW; Pearce-Birge, L | 1 |
Hecht, BK; Hecht, F; Lockwood, D; Sandberg, AA; Tajara, EH | 1 |
Feichtinger, W; Schmid, M | 1 |
Abruzzo, MA; Jacobs, PA; Mayer, M | 1 |
Baker, E; Parslow, MI; Sutherland, GR | 1 |
1 review(s) available for azacitidine and Chromosomal Fragility
Article | Year |
---|---|
Chromosomal fragile sites.
Topics: Aphidicolin; Azacitidine; Blotting, Southern; Bromodeoxyuridine; Chromosome Fragile Sites; Chromosome Fragility; Folic Acid; Humans; Karyotyping; X Chromosome | 1991 |
8 other study(ies) available for azacitidine and Chromosomal Fragility
Article | Year |
---|---|
5-azacytidine decreases the frequency of fragile X expression in peripheral lymphocyte culture.
Topics: Azacitidine; Cells, Cultured; Chromosome Fragility; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Lymphocytes; X Chromosome | 1984 |
Fragile X expression suppressed in either FUdR or methotrexate treated fibroblasts by pretreatment with 5-azacytidine.
Topics: Azacitidine; Chromosome Fragility; Drug Interactions; Female; Fibroblasts; Floxuridine; Gene Expression Regulation; Humans; Male; Methotrexate; X Chromosome | 1984 |
Fragile sites induced by 5-azacytidine and 5-azadeoxycytidine in the murine genome.
Topics: Animals; Azacitidine; Chromosome Banding; Chromosome Fragile Sites; Chromosome Fragility; Decitabine; Mice | 1990 |
DNA demethylation induced by 5-azacytidine does not affect fragile X expression.
Topics: Azacitidine; Cell Line; Chromosome Fragility; DNA; DNA Restriction Enzymes; Fragile X Syndrome; Gene Expression Regulation; Genetic Markers; Humans; Lymphocytes; Male; Methylation; X Chromosome | 1986 |
New common fragile sites.
Topics: Aphidicolin; Azacitidine; Bromodeoxyuridine; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Chromosome Mapping; Diterpenes; Floxuridine; Genetic Markers; Humans; Lymphocytes; Urogenital Neoplasms | 1988 |
Increased frequencies of sister chromatid exchanges at common fragile sites (1)(q42) and (19)(q13).
Topics: Azacitidine; Bromodeoxyuridine; Cells, Cultured; Chromosome Banding; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Decitabine; Humans; Karyotyping; Sister Chromatid Exchange | 1989 |
The effect of methionine and 5-azacytidine on fragile X expression.
Topics: Azacitidine; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Culture Media; DNA; Dose-Response Relationship, Drug; Female; Humans; Lymphocytes; Male; Methionine; Methylation; X Chromosome | 1985 |
New classes of common fragile sites induced by 5-azacytidine and bromodeoxyuridine.
Topics: Adult; Azacitidine; Bromodeoxyuridine; Chromosome Banding; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human, 19-20; Chromosomes, Human, 6-12 and X; Humans; Infant, Newborn; Karyotyping | 1985 |